There has recently been a study published in the American Journal of Psychiatry showing that CBD (or, to give it its full name, cannabidiol), can reduce the psychotic symptoms displayed by people who suffer from schizophrenia and other similar psychiatric disorders.
What Is CBD?
CBD is one of the cannabinoid compounds found in the marijuana plant, and it is famous for its therapeutic benefits which include its anti-seizure, anti-inflammatory and anti-anxiety properties. There is currently a lot of research being done on the effects and benefits of CBD.
This study, led by Philip McGuire, who is one of King’s College London’s professors of psychiatry, involved researchers from around the UK as well as from Romania and Poland. The research covered an 8 week period and was carried out over 15 different hospitals in all three countries. This was the first ever placebo-controlled trial of CBD in a clinical setting as a form of treatment for psychotic patients.
What Is Psychosis?
Psychosis is not actually a disease in its own right. In fact it is a symptom of another underlying disorder and occurs most frequently in people who suffer from other mental illnesses such as schizophrenia, although sometimes people who have brain diseases also suffer from psychosis, which generally manifests itself in the form of delusions or hallucinations.
What Did The Research Discover?
The research team discovered that the patients who were treated with the CBD had significantly fewer symptoms than those patients who took the placebo. Doctors who were responsible for their monitoring in hospital also noted the improvement in the patients condition without being aware of which of the patients in their care were taking CBD.
Although medical experts are not yet completely clear about the way in which CBD works, they do know that it works in a very different way to traditional pharmaceutical anti-psychotic medications, and as a bonus, it produces very few unwanted side effects, which is a huge improvement on medicinal anti-psychotic treatments which produce many such side effects.
Many patients suffering from psychosis are reluctant to take traditional medicines because of fears about the side effects involved, and in around a third of cases, these pharmaceutical medications don’t even work anyway. This means that this study could be vital evidence of the value of CBD as an alternative form of treatment for psychosis for those patients who either would prefer not to take traditional treatments or who find that they do not work in their case.